226 filings
8-K
MBVX
Mabvax Therapeutics Holdings, Inc.
25 Mar 19
Bankruptcy or Receivership
4:49pm
8-K
MBVX
Mabvax Therapeutics Holdings, Inc.
4 Jan 19
MabVax Therapeutics and Oncotelic Enter into Merger Discussions
8:12am
8-K
MBVX
Mabvax Therapeutics Holdings, Inc.
20 Nov 18
Entry into a Material Definitive Agreement
5:05pm
8-K
MBVX
Mabvax Therapeutics Holdings, Inc.
19 Oct 18
Regulation FD Disclosure
9:31pm
8-K
MBVX
Mabvax Therapeutics Holdings, Inc.
16 Oct 18
MabVax Therapeutics Audited Financial Statements Reinstated
8:00am
8-K
ssbk9b7ygr9l67
9 Jul 18
Entry into a Material Definitive Agreement
8:00am
8-K
basv4xvy nd
5 Jul 18
MabVax Therapeutics Receives Nasdaq Delist Determination
5:15pm
8-K
q6hiib fh
3 Jul 18
MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
2:55pm
8-K
h7oy787w
2 Jul 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
1k73zmb
28 Jun 18
MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q
12:00am
8-K
7twp8m hnp7dv402
24 May 18
MabVax Therapeutics Receives Nasdaq Notification Due to Late Form 10-Q
8:10am
8-K/A
q63pna48exw92ndgp1jm
22 May 18
Financial Statements and Exhibits
5:01pm
8-K
1on36cvfrptrzb3m70h
21 May 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10:15am
8-K
74d0buhxm4v4di by
3 May 18
MabVax Therapeutics Holdings, Inc. Announces Private Placement Offering
10:45am
8-K
8qdsrl5
3 May 18
Regulation FD Disclosure
8:38am
8-K
cj1w wwyr
18 Apr 18
MabVax Therapeutics Antibody Program Results Featured in Three Presentations at 2018 American Association for Cancer Research (AACR) Annual Meeting
12:00am
8-K
ejj3omg5v1qlun
13 Apr 18
MabVax Therapeutics Receives Continued Listing Deficiency Notice for Nasdaq’s Minimum Stockholders’ Equity Requirements
12:00am
8-K
ksri49a9vj
2 Apr 18
MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones
12:00am
8-K
0dx q9nm07h017i9wk
6 Mar 18
Regulation FD Disclosure
12:00am
8-K
pqykimn lri9j
28 Feb 18
Regulation FD Disclosure
12:00am